Here’s Why ClearBridge Dividend Strategy is Expecting Considerable Revenue Growth From CVS Health Corporation (CVS)
From Yahoo Finance: 2025-04-08 09:29:00
ClearBridge Investments released its Q1 2025 investor letter, highlighting the resilient ClearBridge Dividend Strategy. Despite a 4.3% decline in the S&P 500 Index, the strategy delivered positive returns. The firm remains cautious but confident in its well-positioned portfolio focused on valuation and strong dividend growth.
In the investor letter, ClearBridge Dividend Strategy spotlighted CVS Health Corporation (NYSE: CVS), emphasizing its potential. CVS saw a one-month return of -6.50% and a 52-week loss of 18.58%. On April 7, 2025, CVS closed at $63.85 per share with a market cap of $80.603 billion.
ClearBridge Dividend Strategy outlined the rationale behind initiating positions in CVS Health Corporation (NYSE: CVS), Inditex, and TE Connectivity. The firm expects profit growth in CVS due to underwriting improvements in its Medicare Advantage program. TE Connectivity presents an attractive entry point with strong business prospects in key markets.
Despite not being among the 30 most popular stocks among hedge funds, CVS Health Corporation (NYSE: CVS) remains a solid investment. While 74 hedge fund portfolios held CVS at the end of Q4, Insider Monkey suggests exploring AI stocks for potentially higher returns within a shorter timeframe. For a promising AI stock trading at a discount, check out their report on the cheapest AI stock.